Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over

Table 2 Recipient characteristics n (%)

	Donors < 70 years old (n = 212)	Donors ≥ 70 years old (n = 212)	P value
Age (yr)	54 (14)	59 (13)	0.00
Gender (male/female)	161/51 (75.9/24.1)	167/45 (78.8/21.2)	0.48
Cirrhosis
Alcoholic	61 (28.8)	95 (44.8)
HBV	13 (6.1)	24 (11.3)	0.00
HCV	105 (49.5)	72 (34.0)
Other	33 (15.6)	21 (9.9)
HCC	82 (38.7)	84 (39.3)	0.89
Child-Pugh
A	47 (22.1)	46 (21.7)
B	75 (35.4)	89 (42)	0.22
C	90 (42.5)	77 (36.3)
MELD	15 (8)	13 (5)	0.20
MELD-Na	16 (11)	14 (9)	0.12
D-MELD	629 (475)	1051 (842)	0.00
Glucose (mg/dL)	107 (44)	105 (48)	0.70
Creatinine (mg/dL)	0.9 (0.4)	0.9 (0.3)	0.07
Total bilirubin (mg/dL)	2.7 (3.4)	1.9 (2.4)	0.10
GOT (IU/L)	54 (67)	58 (58)	0.77
GPT (IU/L)	40 (49)	37 (43)	0.60
Albumin (mg/dL)	3.3 (0.9)	3.4 (1.0)	0.77
Prothrombin activity (%)	62 ± 20 (11.8-120)	65 ± 18 (5-119)	0.07
Platelets (n)	77900 (54925)	82500 (60250)	0.16
UNOS
ICU	0	3 (1.4)	0.77
Hospital	17 (8)	12 (5.7)
Home	195 (92)	197 (92.9)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; D-MELD: The product of donor age and preoperative MELD; GOT: Glutamic-oxaloacetic transaminase; GPT: Glutamic-pyruvic transaminase; UNOS: United network for organ sharing; ICU: Intensive care unit.